16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity (DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social...read more
GH Research, a Phase 2 biotech developing DMT-based therapies for depression, raised $160 million by offering 10 million shares at $16, the high end of the range of $14 to $16. The company offered 1.7 million more shares than anticipated. The company is...read more
GH Research, a Phase 2 biotech developing DMT-based therapies for depression, announced terms for its IPO on Monday. The Dublin, Ireland-based company plans to raise $125 million by offering 8.3 million shares at a price range of $14 to $16. At the midpoint of...read more
Just one IPO entered public markets after the holiday weekend, but the pipeline remained active, with 14 IPOs and 10 SPACs submitting initial filings. Cross-border payment processor dLocal (DLO) priced well above the range to raise...read more
US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week
16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity (DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social...read more
Irish DMT biotech GH Research prices upsized US IPO at $16 high end
GH Research, a Phase 2 biotech developing DMT-based therapies for depression, raised $160 million by offering 10 million shares at $16, the high end of the range of $14 to $16. The company offered 1.7 million more shares than anticipated. The company is...read more
Irish DMT biotech GH Research sets terms for $125 million US IPO
GH Research, a Phase 2 biotech developing DMT-based therapies for depression, announced terms for its IPO on Monday. The Dublin, Ireland-based company plans to raise $125 million by offering 8.3 million shares at a price range of $14 to $16. At the midpoint of...read more
US IPO Weekly Recap: June kicks off with a quiet 1 IPO week
Just one IPO entered public markets after the holiday weekend, but the pipeline remained active, with 14 IPOs and 10 SPACs submitting initial filings. Cross-border payment processor dLocal (DLO) priced well above the range to raise...read more